Nano-X AI
About Nano-X AI
Nano-X Imaging Ltd. (NASDAQ: NNOX), often referred to as Nanox, is a medical imaging technology company dedicated to increasing the accessibility and affordability of diagnostic medicine globally. The company’s integrated, end-to-end platform combines innovative hardware with advanced artificial intelligence (AI) solutions and cloud-based services. At its core is the Nanox.ARC, an FDA-cleared and CE-marked multi-source digital tomosynthesis imaging system designed for cost-effective, high-resolution 3D imaging, aiming to expand medical imaging capabilities both within and beyond traditional hospital settings.
Nanox.AI, a key subsidiary, develops a suite of FDA-cleared AI-based algorithms that augment the interpretation of routine CT imaging. These solutions are designed to identify early signs of prevalent chronic diseases that might otherwise go unnoticed. For instance, HealthCCSng detects coronary artery calcium, an indicator of coronary artery disease; HealthOST assesses bone mineral density and identifies vertebral compression fractures, key warning signs of osteoporosis; and HealthFLD measures liver density, which can indicate fatty liver disease. By integrating these AI-driven insights into clinical workflows, Nanox.AI aims to empower physicians with actionable information, facilitate earlier detection, and enable the establishment of preventative care pathways, ultimately enhancing patient outcomes and improving clinical efficiency.
The Nanox ecosystem further includes Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics, and Nanox.MARKETPLACE (through its subsidiary USARAD Holdings Inc.), which provides access to remote radiology and cardiology experts and comprehensive teleradiology services. This comprehensive approach, integrating imaging technology, AI, cloud infrastructure, and clinical expertise, seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
Focus Areas
Business Intelligence
| Key Investors | BlackRock, State Street Corp, UBS Group AG, ARK Investment Management LLC, SK Telecom, Foxconn, Yozma Korea, Industrial Alliance |
| Partnerships | 3DR Labs, Ferrum Health, Nuance Precision Imaging Network, Monarch Medical Management and Billing LLC |
| Acquisitions | Nano-X AI (formerly Zebra Medical Vision LTD) in 2021, USARAD Holdings Inc., MDWEB, LLC, VasoHealthcare IT in 2025 |
| Technology | AI-based suite of algorithms, cloud-native (Nanox.CLOUD), leverages routine CT imaging data, digital X-ray source technology (Nanox.ARC ecosystem) |
| FDA Clearances | 3 (HealthCCSng, HealthOST, HealthFLD for AI solutions) cleared products (estimated) |
What Physicians Need to Know
Nano-X AI offers physicians a powerful tool to enhance diagnostic capabilities by leveraging existing CT scans for opportunistic screening of chronic diseases. The FDA-cleared solutions (HealthFLD, HealthCCSng, HealthOST) provide actionable insights, such as quantifying coronary artery calcification or identifying vertebral compression fractures, which can be seamlessly integrated into radiology reports. This enables earlier detection of often asymptomatic conditions, facilitating timely interventions and preventive care pathways. The automated analysis minimizes additional workload, while potentially improving patient outcomes, reducing critical events, and supporting value-based care models through more accurate risk adjustment and CPT code utilization.
Nano-X AI solutions are designed for seamless integration with existing Picture Archiving and Communication Systems (PACS). They also connect to the Nuance Precision Imaging Network and are integrated into Nanox's Second Opinions online medical consultation service (a USARAD subsidiary), providing a comprehensive and connected ecosystem for medical imaging and AI-powered analytics.
What the Web Says
Nano-X AI, a subsidiary of Nano-X Imaging, focuses on developing AI solutions for medical imaging, particularly for early detection of chronic diseases from routine CT scans. The company's core product, Nanox.AI, offers solutions like HealthCCSng for cardiac conditions, HealthOST for bone density and fractures, and HealthFLD for fatty liver disease. While the technology shows promise in improving early diagnosis and preventative care, the company faces challenges in scaling its operations and achieving profitability. There's also some skepticism regarding the initial marketing hype surrounding its imaging technology.
Overall: MixedStrengths
- AI-powered solutions for early detection of chronic diseases from routine CT scans.
- Potential to improve patient outcomes and reduce healthcare burden through earlier diagnosis.
- FDA-cleared AI solutions.
- Cost-effective alternative to traditional X-ray machines with the Nanox.ARC system.
- Strong potential for market disruption with novel X-ray tube technology.
- Proven value in increasing detection of coronary calcification and spine fractures.
Limitations
- Skepticism and concerns about initial marketing hype and product demonstrations.
- Slow execution and deployment of imaging systems.
- Challenges in converting technological foundations into substantial revenue.
- Negative cash flow from operations and potential need for additional financing.
- Underdeveloped investor outreach and marketing.
- Some Reddit discussions express concerns about the company's stock and past rumors.
Based on reviews from: Reddit, AuntMinnie, G2, Seeking Alpha, Indeed.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about Nano-X AI.
Videos load interactively. If none appear, search YouTube for Nano-X AI →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]